{"id":"analog-or-human-insulin","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Hypoglycemia"},{"rate":"10-20%","effect":"Weight gain"},{"rate":"null","effect":"Allergic reactions"}]},"_chembl":{"chemblId":"CHEMBL1201631","moleculeType":"Protein"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Human insulin analogs are designed to have a faster onset of action or a longer duration of action compared to natural insulin, allowing for more precise glucose control. They work by binding to insulin receptors on cells, triggering the uptake of glucose from the bloodstream into the cells.","oneSentence":"Human insulin analogs mimic the action of the body's natural insulin, helping to lower blood sugar levels.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T04:09:10.688Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 1 diabetes"},{"name":"Type 2 diabetes"}]},"trialDetails":[{"nctId":"NCT06904846","phase":"NA","title":"To Evaluate the Change in Glucose Parameters in Adult Patients With Type 1 or Type 2 Diabetes From Europe Using the iCan o3 CGM System for 60 Days Period","status":"ENROLLING_BY_INVITATION","sponsor":"Sinocare","startDate":"2025-04-23","conditions":"Diabetes Mellitus, Continuous Glucose Monitoring System","enrollment":70},{"nctId":"NCT02546401","phase":"PHASE3","title":"Comparison of Insulin's Injection Before or After the Meal in Type 1 Diabetic Patients Treated With Insulin Pump","status":"COMPLETED","sponsor":"University Hospital, Brest","startDate":"2015-09","conditions":"Diabetes Type 1","enrollment":22},{"nctId":"NCT05614089","phase":"PHASE4","title":"Human Versus Analogue Insulin for Youth With Type 1 Diabetes in Low-Resource Settings","status":"COMPLETED","sponsor":"Jing Luo","startDate":"2023-03-15","conditions":"Diabetes Mellitus, Type 1, Type 1 Diabetes","enrollment":400},{"nctId":"NCT05888961","phase":"NA","title":"Single-center Prospective Longitudinal Study of Taste in Patients With Cognitive Disorders at Different Stages of Severity (Isolated Cognitive Complaint, Minor or Major Neurocognitive Alzheimer-type Disorders) by Analysis of Gustatory Evoked Potentials","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2023-06-12","conditions":"Cognitive Disorders","enrollment":72},{"nctId":"NCT04974528","phase":"PHASE3","title":"Afrezza® INHALE-1 Study in Pediatrics","status":"COMPLETED","sponsor":"Mannkind Corporation","startDate":"2021-09-29","conditions":"Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2","enrollment":319},{"nctId":"NCT06411210","phase":"PHASE2","title":"Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment","status":"RECRUITING","sponsor":"Yale University","startDate":"2024-07-16","conditions":"Diabetes type1, Obesity","enrollment":54},{"nctId":"NCT06577584","phase":"","title":"Comparison of Diabetes Patients - Care Trajectory Versus Convention","status":"NOT_YET_RECRUITING","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2025-02-01","conditions":"Type 2 Diabetes","enrollment":20000},{"nctId":"NCT06624943","phase":"PHASE4","title":"Introducing Biosimilar Insulin Glargine to the Treatment Regimen of Children and Youth with Type 1 Diabetes in Mali","status":"COMPLETED","sponsor":"Life for a Child Program, Diabetes Australia","startDate":"2022-03-14","conditions":"Type 1 Diabetes (T1D)","enrollment":260},{"nctId":"NCT05904743","phase":"PHASE4","title":"INHALE-3: Afrezza® Combined With Insulin Degludec Versus Usual Care in Adults With Type 1 Diabetes","status":"COMPLETED","sponsor":"Mannkind Corporation","startDate":"2023-07-07","conditions":"Diabetes Mellitus, Type 1","enrollment":141},{"nctId":"NCT03380546","phase":"PHASE3","title":"Acarbose and Prandial Insulin for the Treatment of Gestational Diabetes Mellitus.","status":"TERMINATED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2018-07-04","conditions":"Gestational Diabetes Mellitus in Pregnancy","enrollment":341},{"nctId":"NCT02871089","phase":"NA","title":"Closed Loop From Onset in Type 1 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Cambridge","startDate":"2017-01","conditions":"Diabetes Mellitus, Type 1 Diabetes","enrollment":96},{"nctId":"NCT04186494","phase":"NA","title":"Effect of Liraglutide vs CPAP on Cardiometabolic Outcomes in Obstructive Sleep Apnea","status":"COMPLETED","sponsor":"St Vincent's University Hospital, Ireland","startDate":"2019-12-02","conditions":"Sleep Apnea, Obstructive","enrollment":30},{"nctId":"NCT04849845","phase":"PHASE4","title":"Afrezza® Dosing Optimization Study","status":"COMPLETED","sponsor":"Mannkind Corporation","startDate":"2021-04-09","conditions":"Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2","enrollment":20},{"nctId":"NCT05389813","phase":"PHASE2, PHASE3","title":"Comparison Between Oxycodone and Pregabalin as Preemptive Analgesia","status":"UNKNOWN","sponsor":"An-Najah National University","startDate":"2021-08-15","conditions":"Anesthesia","enrollment":150},{"nctId":"NCT03770767","phase":"PHASE3","title":"Insulin Fiasp vs. Insulin Novorapid During Pregnancy and Laction in Women With Pre-existing Diabetes","status":"COMPLETED","sponsor":"Rigshospitalet, Denmark","startDate":"2019-11-11","conditions":"Diabetes Mellitus, Pregnancy Complications","enrollment":216},{"nctId":"NCT05095259","phase":"NA","title":"Metabolic Adaptation to High-frequent Hypoglycaemia in Type 1 Diabetes","status":"UNKNOWN","sponsor":"Nordsjaellands Hospital","startDate":"2019-12-16","conditions":"Type1diabetes","enrollment":60},{"nctId":"NCT02152124","phase":"","title":"Growth Hormone, IGF-1 and Medical Treatment in Acromegaly: Are There Effects on Gut Hormone Physiology and Postprandial Substrate Metabolism?","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2014-06-01","conditions":"Acromegaly","enrollment":21},{"nctId":"NCT04860414","phase":"NA","title":"Prospective Monocentric Study of Taste in Patients With Minor or Major Cognitive Disorders Such as Alzheimer's, Through the Analysis of Gustatory Evoked Potentials.","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2021-03-03","conditions":"Cognitive Disorders","enrollment":45},{"nctId":"NCT03234491","phase":"PHASE1","title":"Improving Post-Prandial Blood Glucose Control With Afrezza During Closed-Loop Therapy","status":"COMPLETED","sponsor":"Yale University","startDate":"2017-11-22","conditions":"Post-Prandial Hyperglycemia, Post-Prandial Hypoglycemia","enrollment":15},{"nctId":"NCT05360147","phase":"PHASE3","title":"Liraglutide Improve Cognitive Function in Patients With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Third Military Medical University","startDate":"2021-01-20","conditions":"Type 2 Diabetes Mellitus","enrollment":30},{"nctId":"NCT03260868","phase":"PHASE4","title":"Evaluation of Virtual Versus Traditional Study Conducted in a Group Pilot Study in Adult Patients With Type 1 Diabetes Mellitus (eStudy)","status":"TERMINATED","sponsor":"Sanofi","startDate":"2017-09-19","conditions":"Type 1 Diabetes Mellitus","enrollment":15},{"nctId":"NCT03336528","phase":"PHASE4","title":"Insulin Degludec and Glargine U100 for Management of Hospitalized and Discharged Patients With Type 2 Diabetes","status":"COMPLETED","sponsor":"Emory University","startDate":"2018-01-02","conditions":"Type 2 Diabetes","enrollment":180},{"nctId":"NCT02688933","phase":"PHASE4","title":"A Study Comparing the Efficacy and Safety of the Morning Injection of Toujeo Versus Lantus in Patients With Type 1 Diabetes Mellitus","status":"COMPLETED","sponsor":"Sanofi","startDate":"2016-05-05","conditions":"Type 1 Diabetes Mellitus","enrollment":638},{"nctId":"NCT02735044","phase":"PHASE3","title":"Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Children and Adolescents With Type 1 Diabetes Mellitus","status":"COMPLETED","sponsor":"Sanofi","startDate":"2016-04-14","conditions":"Type 1 Diabetes Mellitus","enrollment":463},{"nctId":"NCT01499082","phase":"PHASE3","title":"Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime Insulin","status":"COMPLETED","sponsor":"Sanofi","startDate":"2011-12","conditions":"Type 2 Diabetes Mellitus","enrollment":807},{"nctId":"NCT04031599","phase":"NA","title":"Assessment of the Efficacy of the Artificial Pancreas Combined With a Qualitative Meal Size Estimation to Control Postprandial Glucose Levels","status":"COMPLETED","sponsor":"Institut de Recherches Cliniques de Montreal","startDate":"2020-07-10","conditions":"Type 1 Diabetes","enrollment":30},{"nctId":"NCT04834362","phase":"PHASE4","title":"Insulin for Hyperglycemia in Stroke Trial","status":"COMPLETED","sponsor":"National Institute of Neurosciences and Hospital, Dhaka","startDate":"2021-04-05","conditions":"Hyperglycemia, Stroke, Acute","enrollment":452},{"nctId":"NCT04323462","phase":"PHASE4","title":"Intensive Glycemic Control For Diabetic Foot Ulcer Healing","status":"UNKNOWN","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2021-10-01","conditions":"Diabetic Foot Ulcer","enrollment":326},{"nctId":"NCT03430284","phase":"PHASE4","title":"Multifactorial Intervention on Diabetes (MIDiab Study)","status":"UNKNOWN","sponsor":"Shandong Provincial Hospital","startDate":"2018-04-01","conditions":"Diabetes Mellitus, Type 2","enrollment":6300},{"nctId":"NCT04146155","phase":"PHASE4","title":"Efficacy and Safety of Liraglutide in Type 2 Diabetes With Lower Extremity Arterial Disease","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2020-05-01","conditions":"Type 2 Diabetes, Peripheral Vascular Disorder Due to Diabetes Mellitus","enrollment":200},{"nctId":"NCT04626323","phase":"PHASE2","title":"Randomized Study Comparing Metabolic Surgery With Intensive Medical Therapy to Treat Diabetic Kidney Disease","status":"UNKNOWN","sponsor":"Hospital Alemão Oswaldo Cruz","startDate":"2021-05-25","conditions":"Diabetes Mellitus, Type 2, Kidney Disease, Chronic, Kidney Injury","enrollment":60},{"nctId":"NCT02407899","phase":"PHASE4","title":"Protective Effects of Saxagliptin (And Vitamin D3) on β Cell Function in Adult-onset Latent Autoimmune Diabetes","status":"COMPLETED","sponsor":"Second Xiangya Hospital of Central South University","startDate":"2015-03","conditions":"Diabetes Mellitus, Type 1","enrollment":300},{"nctId":"NCT03338023","phase":"PHASE3","title":"A Study of LY2963016 Compared to Lantus® in Adult Chinese Participants With Type 1 Diabetes Mellitus","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2018-03-23","conditions":"Type 1 Diabetes","enrollment":272},{"nctId":"NCT02432976","phase":"PHASE2, PHASE3","title":"Impact of Perioperative Exenatide Infusion on Quality of Life in Cardiac Surgery Patients","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Besancon","startDate":"2015-05","conditions":"Quality of Life","enrollment":64},{"nctId":"NCT03819790","phase":"PHASE4","title":"The Effect of Soliqua on Glucose Variability in Type 2 Patients Among South Asians","status":"COMPLETED","sponsor":"LMC Diabetes & Endocrinology Ltd.","startDate":"2018-10-02","conditions":"Diabetes Mellitus, Type 2","enrollment":119},{"nctId":"NCT04726631","phase":"NA","title":"Insulin in Treatment of Diabetes Mellitus With Pregnancy","status":"COMPLETED","sponsor":"Assiut University","startDate":"2015-01-01","conditions":"Diabetes","enrollment":110},{"nctId":"NCT04690309","phase":"PHASE4","title":"Human Versus Analogue Insulin in Patients After Pancreatectomy.","status":"UNKNOWN","sponsor":"Polish Society of Diabetology","startDate":"2018-07-01","conditions":"Pancreatogenous Diabetes","enrollment":100},{"nctId":"NCT00700154","phase":"NA","title":"Insulin Infusion Diabetes Ulcer","status":"TERMINATED","sponsor":"Karolinska Institutet","startDate":"2011-11","conditions":"Diabetes Mellitus, Insulin Resistance, Hyperglycemia","enrollment":40},{"nctId":"NCT04196231","phase":"PHASE4","title":"Durability of Combination of Insulin and GLP-1 Receptor Agonist or SGLT-2 Inhibitors Versus Basal Bolus Insulin Regimen in Type 2 Diabetes (BEYOND)","status":"COMPLETED","sponsor":"University of Campania Luigi Vanvitelli","startDate":"2019-11-27","conditions":"Type 2 Diabetes","enrollment":258},{"nctId":"NCT00700362","phase":"","title":"Insulin Infusion and Infectious Diabetic Foot Ulcers (IIIFU)","status":"WITHDRAWN","sponsor":"Karolinska Institutet","startDate":"2011-12","conditions":"Diabetes Mellitus, Insulin Resistance, Hyperglycemia","enrollment":""},{"nctId":"NCT02846831","phase":"PHASE2","title":"Closed-loop Control of Glucose Levels (Artificial Pancreas) for 12 Days in Adults With Type 1 Diabetes","status":"COMPLETED","sponsor":"Institut de Recherches Cliniques de Montreal","startDate":"2019-01-24","conditions":"Type 1 Diabetes","enrollment":36},{"nctId":"NCT04222348","phase":"PHASE3","title":"MeDiGes Study: Metformine Use in Gestational Diabetes","status":"UNKNOWN","sponsor":"Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud","startDate":"2016-10-26","conditions":"Diabetes, Gestational, Perinatal Disorder, Puerperal Disorder","enrollment":200},{"nctId":"NCT04112069","phase":"NA","title":"The Insulin-Only Bionic Pancreas Bridging Study- Pediatric Transitional Study","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2018-07-09","conditions":"Type1 Diabetes Mellitus","enrollment":20},{"nctId":"NCT02043054","phase":"PHASE3","title":"Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA)","status":"COMPLETED","sponsor":"University of Leicester","startDate":"2013-12-16","conditions":"Type 2 Diabetes Mellitus, Cardiovascular Disease","enrollment":90},{"nctId":"NCT03858062","phase":"NA","title":"Algorithm to Control Postprandial, Post Exercise and Night Glucose Excursions in a Portable Closed Loop Format,","status":"COMPLETED","sponsor":"J.H. DeVries","startDate":"2019-03-10","conditions":"Diabetes Mellitus, Type 1","enrollment":36},{"nctId":"NCT03552523","phase":"NA","title":"The Set-Point Study for Type 2 Diabetes: Evaluating the Use of an Insulin Only Bionic Pancreas System in Type 2 Diabetes","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2017-07-28","conditions":"Type 2 Diabetes Mellitus","enrollment":16},{"nctId":"NCT03565666","phase":"PHASE2, PHASE3","title":"The Insulin-Only Bionic Pancreas Bridging Study","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2018-07-09","conditions":"Type1 Diabetes Mellitus","enrollment":36},{"nctId":"NCT02846857","phase":"PHASE2","title":"Closed-loop Control of Glucose Levels (Artificial Pancreas) for 15 Weeks in Adolescents and Adults With Type 1 Diabetes","status":"WITHDRAWN","sponsor":"Institut de Recherches Cliniques de Montreal","startDate":"","conditions":"Type 1 Diabetes","enrollment":""},{"nctId":"NCT02455076","phase":"PHASE4","title":"Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of Patients With Type 2 Diabetes","status":"COMPLETED","sponsor":"Emory University","startDate":"2015-09","conditions":"Type 2 Diabetes","enrollment":150},{"nctId":"NCT02490085","phase":"PHASE2","title":"Closed-loop Control of Glucose Levels (Artificial Pancreas) for 24 Hours in Adults With Type 2 Diabetes Under Intensive Insulin Therapy","status":"COMPLETED","sponsor":"Institut de Recherches Cliniques de Montreal","startDate":"2015-10","conditions":"Type 2 Diabetes","enrollment":15},{"nctId":"NCT02855307","phase":"PHASE2","title":"Closed-loop Control of Glucose Levels (Artificial Pancreas) During Postprandial Exercise in Adults With Type 1 Diabetes","status":"COMPLETED","sponsor":"Institut de Recherches Cliniques de Montreal","startDate":"2016-09","conditions":"Type 1 Diabetes","enrollment":37},{"nctId":"NCT01009580","phase":"PHASE3","title":"Comparison of NN5401 With Biphasic Insulin Aspart 30 in Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2009-11-05","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":447},{"nctId":"NCT01774565","phase":"NA","title":"Closed-loop Insulin Delivery in the General Ward","status":"COMPLETED","sponsor":"University of Cambridge","startDate":"2016-08","conditions":"Diabetes Mellitus","enrollment":43},{"nctId":"NCT03682640","phase":"PHASE2","title":"Azithromycin Insulin Diet Intervention Trial in Type 1 Diabetes","status":"UNKNOWN","sponsor":"Uppsala University","startDate":"2018-09","conditions":"Diabetes Mellitus, Type 1, Diabetes Mellitus, Metabolic Disease","enrollment":60},{"nctId":"NCT01792830","phase":"PHASE3","title":"Efficacy and Safety of a Glargine-based Hospital Discharge Algorithm in Coronary Artery Bypass Graft (CABG) Patients","status":"COMPLETED","sponsor":"Emory University","startDate":"2012-10","conditions":"Poor Glycemic Control","enrollment":175},{"nctId":"NCT02059174","phase":"PHASE1","title":"A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-1293 Compared With a Basal Insulin in Participants With Type 1 Diabetes (MK-1293-005)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2014-02-10","conditions":"Type 1 Diabetes Mellitus","enrollment":76},{"nctId":"NCT00442767","phase":"PHASE4","title":"Post-meal Insulin Dosing With Adjuvant Pre-meal Pramlintide in Children With Type 1 Diabetes Mellitus","status":"COMPLETED","sponsor":"Montefiore Medical Center","startDate":"2007-02","conditions":"Type 1 Diabetes Mellitus","enrollment":8},{"nctId":"NCT01215331","phase":"PHASE3","title":"Gestational Diabetes: Insulin or Oral Hypoglycemic Agents?","status":"COMPLETED","sponsor":"Université de Sherbrooke","startDate":"2010-08","conditions":"Gestational Diabetes Mellitus","enrollment":73},{"nctId":"NCT03463564","phase":"PHASE4","title":"Insulin Pump vs Multiple Daily Injections of Insulin and Glyco-metabolic Control in Type 1 Diabetic Patients","status":"RECRUITING","sponsor":"University of Campania Luigi Vanvitelli","startDate":"2016-01","conditions":"Type 1 Diabetes Mellitus","enrollment":150},{"nctId":"NCT02276859","phase":"PHASE4","title":"Normal Versus Dual Wave Insulin Bolus for High-protein Food","status":"COMPLETED","sponsor":"Medical University of Warsaw","startDate":"2014-10","conditions":"Type 1 Diabetes","enrollment":70},{"nctId":"NCT02488616","phase":"PHASE2","title":"Closed-loop Control of Glucose Levels (Artificial Pancreas) for 5 Days in Adults With Type 1 Diabetes","status":"WITHDRAWN","sponsor":"Institut de Recherches Cliniques de Montreal","startDate":"2018-03","conditions":"Type 1 Diabetes","enrollment":""},{"nctId":"NCT02774876","phase":"PHASE2","title":"Closed-loop Control of Postprandial Glucose Levels After Meals With Different Macronutrients Content in Adults With Type 1 Diabetes","status":"COMPLETED","sponsor":"Institut de Recherches Cliniques de Montreal","startDate":"2016-06","conditions":"Type 1 Diabetes","enrollment":15},{"nctId":"NCT02490098","phase":"PHASE2","title":"Closed-loop Control of Postprandial Glucose Levels in Children and Adults With Type 1 Diabetes","status":"WITHDRAWN","sponsor":"Institut de Recherches Cliniques de Montreal","startDate":"2018-01","conditions":"Type 1 Diabetes","enrollment":""},{"nctId":"NCT02302716","phase":"PHASE3","title":"A Study of LY2963016 Compared to LANTUS® in Adult Participants With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2014-12","conditions":"Diabetes Mellitus, Type 2","enrollment":493},{"nctId":"NCT01969149","phase":"PHASE2, PHASE3","title":"Exenatide for Stress Hyperglycemia","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Besancon","startDate":"2015-01","conditions":"Stress Hyperglycemia","enrollment":110},{"nctId":"NCT00600886","phase":"PHASE3","title":"Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2008-02-11","conditions":"Acromegaly","enrollment":358},{"nctId":"NCT02798250","phase":"PHASE2","title":"Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation - Part 2","status":"COMPLETED","sponsor":"Institut de Recherches Cliniques de Montreal","startDate":"2016-06","conditions":"Type 1 Diabetes","enrollment":11},{"nctId":"NCT00659295","phase":"","title":"Observational Study to Evaluate the Safety of Levemir® in Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2004-06","conditions":"Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2","enrollment":51170},{"nctId":"NCT00184600","phase":"PHASE3","title":"Comparison of Insulin Detemir, Insulin Aspart and Biphasic Insulin Aspart 30 With OAD Treatment in Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2004-11","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":708},{"nctId":"NCT01617434","phase":"PHASE3","title":"The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2012-09","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":451},{"nctId":"NCT01006291","phase":"PHASE3","title":"Comparison of NN1250 With Insulin Glargine in Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2009-11","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":687},{"nctId":"NCT01707134","phase":"PHASE3","title":"Safety and Efficacy of Insulin Aspart in Subjects With Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"1997-09","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":753},{"nctId":"NCT02476760","phase":"","title":"Incretin-based Drugs and Acute Pancreatitis","status":"COMPLETED","sponsor":"Canadian Network for Observational Drug Effect Studies, CNODES","startDate":"2014-03","conditions":"Diabetes Mellitus, Type 2","enrollment":1417914},{"nctId":"NCT00806936","phase":"","title":"Observational Study to Investigate the Efficacy and Safety of Human Insulin or Insulin Analogue Treatments in Type 2 Diabetes Subjects","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2008-12","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":4847},{"nctId":"NCT02535299","phase":"PHASE4","title":"Par-4 and Telomere-telomerase System in Type 2 Diabetes Patients Who Received GLP-1 or Metformin Treatment","status":"UNKNOWN","sponsor":"Third Military Medical University","startDate":"2016-06","conditions":"GLP-1；Metformin；Telomere-telomerase System；Par-4","enrollment":200},{"nctId":"NCT02685449","phase":"PHASE4","title":"Insulin Requirement for Pure-protein Meal in Children With Type 1 Diabetes on Insulin Pumps.","status":"UNKNOWN","sponsor":"Medical University of Warsaw","startDate":"2016-02","conditions":"Diabetes type1","enrollment":70},{"nctId":"NCT02419859","phase":"NA","title":"A Study to Assess Insulin Delivery With PaQ® in Patients With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"CeQur Corporation","startDate":"2015-02","conditions":"Type 2 Diabetes Mellitus","enrollment":20},{"nctId":"NCT01040819","phase":"PHASE4","title":"Does Pioglitazone Increase the Production of 15-EPI-Lipoxin A4?","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2010-02","conditions":"Type 2 Diabetes Mellitus","enrollment":25},{"nctId":"NCT02626936","phase":"PHASE2","title":"Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation","status":"COMPLETED","sponsor":"Institut de Recherches Cliniques de Montreal","startDate":"2016-01","conditions":"Type 1 Diabetes","enrollment":10},{"nctId":"NCT02456428","phase":"","title":"Incretin-based Drugs and the Risk of Heart Failure","status":"COMPLETED","sponsor":"Canadian Network for Observational Drug Effect Studies, CNODES","startDate":"2014-03","conditions":"Type 2 Diabetes Mellitus","enrollment":1499650},{"nctId":"NCT01933529","phase":"PHASE2","title":"ARA290 in T2D (Effects of ARA 290, an Erythropoietin Analogue) in Prediabetes and Type 2 Diabetes)","status":"UNKNOWN","sponsor":"Claes-Göran Östenson","startDate":"2013-10","conditions":"Diabetes Type 2, Impaired Glucose Tolerance, Impaired Fasting Glucose","enrollment":24},{"nctId":"NCT02012166","phase":"PHASE1","title":"A Study of MK-0893 on Glucagon-Induced Glycemic Excursion in Healthy Male Participants Following Intravenous Administration of Glucagon, Sandostatine® and Insulin (MK-0893-002)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2005-07","conditions":"Type 2 Diabetes Mellitus","enrollment":18},{"nctId":"NCT00934336","phase":"NA","title":"Importance in Type 1 Diabetes Patients of an Optimized Control of Post-Prandial Glycaemia on Oxidant Stress Prevention","status":"COMPLETED","sponsor":"Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète","startDate":"2008-11","conditions":"Type 1 Diabetes","enrollment":50},{"nctId":"NCT01683266","phase":"PHASE3","title":"Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus","status":"COMPLETED","sponsor":"Sanofi","startDate":"2012-09","conditions":"Type 1 Diabetes Mellitus","enrollment":549},{"nctId":"NCT02438397","phase":"PHASE4","title":"the Efficacy of Acarbose and Metformin on Blood Glucose Fluctuation When Combined With Premix Insulin","status":"UNKNOWN","sponsor":"Shanghai 6th People's Hospital","startDate":"2014-12","conditions":"Type 2 Diabetes","enrollment":80},{"nctId":"NCT00635492","phase":"","title":"CHOICE: CHanges to Treatment and Outcomes in Patients With Type 2 Diabetes Initiating InjeCtablE Therapy","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2008-01","conditions":"Type 2 Diabetes Mellitus","enrollment":2515},{"nctId":"NCT01363609","phase":"NA","title":"Effects of Glucagon Like Peptide-1(GLP-1) and Liraglutide on Brain Satiety and Reward Circuits and Feeding Behavior in Diabetes","status":"COMPLETED","sponsor":"Amsterdam UMC, location VUmc","startDate":"2011-10","conditions":"Obesity, Type 2 Diabetes","enrollment":50},{"nctId":"NCT01240785","phase":"PHASE4","title":"Metformin Versus Insulin in Gestational Diabetes","status":"COMPLETED","sponsor":"Turku University Hospital","startDate":"2006-06","conditions":"Gestational Diabetes","enrollment":221},{"nctId":"NCT00747006","phase":"PHASE2","title":"Safety and Efficacy of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder)When an Optimal Dose is Taken With Varied Carbohydrate Intake","status":"TERMINATED","sponsor":"Mannkind Corporation","startDate":"2008-09","conditions":"Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1","enrollment":18},{"nctId":"NCT01421147","phase":"PHASE3","title":"A Study in Adults With Type 1 Diabetes","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2011-08","conditions":"Diabetes Mellitus, Type 1","enrollment":536},{"nctId":"NCT00883558","phase":"PHASE2","title":"Safety Study of Subcutaneously-Injected Prandial INSULIN-PH20 NP Compared to Insulin Lispro Injection in Participants With Type 1 Diabetes Mellitus","status":"COMPLETED","sponsor":"Halozyme Therapeutics","startDate":"2009-05","conditions":"Diabetes Mellitus, Type 1","enrollment":48},{"nctId":"NCT00522210","phase":"NA","title":"Comparison of a Twice Daily Versus a Three Times Daily Insulin Regimen in Children With Type 1 Diabetes","status":"COMPLETED","sponsor":"University of Calgary","startDate":"2008-03","conditions":"Type 1 Diabetes","enrollment":18},{"nctId":"NCT01355718","phase":"","title":"Observational, Safety Study of NovoNorm® (Repaglinide) and Insulin Analogue Combination Therapy in Type 2 Diabetes in Korea","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2011-08","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":120},{"nctId":"NCT00979875","phase":"PHASE1","title":"A Pharmacokinetic and Glucodynamic Study of Subcutaneously Administered Insulin Analogs With rHuPH20 Compared to Insulin Analogs Alone","status":"COMPLETED","sponsor":"Halozyme Therapeutics","startDate":"2009-09","conditions":"Healthy","enrollment":14},{"nctId":"NCT00862875","phase":"PHASE4","title":"Levemir-Body Composition and Energy Metabolism","status":"COMPLETED","sponsor":"Institut de Recherches Cliniques de Montreal","startDate":"2009-03","conditions":"Type 2 Diabetes","enrollment":42},{"nctId":"NCT00239707","phase":"PHASE1","title":"GIP: Glucose-dependent Insulinotropic Peptide","status":"COMPLETED","sponsor":"National Institute on Aging (NIA)","startDate":"2003-02","conditions":"Type 2 Diabetes","enrollment":41},{"nctId":"NCT01147627","phase":"NA","title":"Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patients","status":"COMPLETED","sponsor":"Sun Yat-sen University","startDate":"2010-08","conditions":"Diabetes Mellitus, Type 2, Newly Diagnosed","enrollment":416},{"nctId":"NCT01828970","phase":"PHASE4","title":"Pilot Study of Glycemic Control in Diabetic Hemodialyzed Patients","status":"COMPLETED","sponsor":"Centre Europeen d'Etude du Diabete","startDate":"2010-01","conditions":"Diabetes Mellitus","enrollment":38},{"nctId":"NCT01438632","phase":"PHASE4","title":"Pharmacology of Insulin Injected With Jet-injection in Diabetes","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2011-09","conditions":"Diabetes Mellitus","enrollment":24},{"nctId":"NCT01150617","phase":"PHASE4","title":"Normalization of Fasting Glucose and the Incidence of Restenosis After Peripheral Angioplasty","status":"TERMINATED","sponsor":"IRCCS San Raffaele","startDate":"2008-12","conditions":"Type 2 Diabetes Mellitus, Peripheral Vascular Disease","enrollment":46}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1187067,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Analog or Human Insulin","genericName":"Analog or Human Insulin","companyName":"Eli Lilly and Company","companyId":"eli-lilly","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Human insulin analogs mimic the action of the body's natural insulin, helping to lower blood sugar levels. Used for Type 1 diabetes, Type 2 diabetes.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}